Sunday, March 09, 2008 11:39:49 AM
7 Highly Rated Stocks on Sale
By Matt Koppenheffer February 27, 2008
7
Recommendations
I am always looking for a good deal. I buy extra boxes of Cocoa Puffs when they're on sale, and I pounce on undervalued stocks.
The idea that anybody would sell a stock for less than its worth might seem silly, but legendary value investor Ben Graham tells us, by way of allegory, how we can find these situations.
In The Intelligent Investor, Graham introduces readers to a wacky guy named Mr. Market. Mr. Market's game is to pay you house calls every day, and he offers to sell you interests in businesses he owns or to buy from you interests in businesses you own. Sometimes Mr. Market shows up at your door very excited, and offers you premium prices for your holdings. Other times he is inconsolably depressed about the future and will offer to sell you what he has for as low as pennies on the dollar.
So to find some of those stocks that make Mr. Market weepy, I turn once again to The Motley Fool's CAPS investor community. Each of the companies below had been given a five-star rating (the highest) by our community of investors just 30 days ago:
Stock
30-day Return
One-year Return
Current CAPS Rating
Sigma Designs (Nasdaq: SIGM)
(34.0%)
13.1%
****
Ceradyne (Nasdaq: CRDN)
(19.5%)
(30.7%)
*****
Hardinge (Nasdaq: HDNG)
(18.6%)
(43.1%)
*****
Actuate (Nasdaq: ACTU)
(18.6%)
(2.7%)
****
Gen-Probe (Nasdaq: GPRO)
(10.6%)
8.7%
****
China Security & Surveillance Technology (NYSE: CSR)
(9.2%)
0.0%
*****
ASML Holding (Nasdaq: ASML)
(8.7%)
(0.5%)
*****
Data from Motley Fool CAPS as of Feb. 26.
As the table shows, these stocks are all still highly regarded by the CAPS community despite their underperformance over the past month. These are not formal recommendations, but they could be a great place to kick off further research.
By Matt Koppenheffer February 27, 2008
7
Recommendations
I am always looking for a good deal. I buy extra boxes of Cocoa Puffs when they're on sale, and I pounce on undervalued stocks.
The idea that anybody would sell a stock for less than its worth might seem silly, but legendary value investor Ben Graham tells us, by way of allegory, how we can find these situations.
In The Intelligent Investor, Graham introduces readers to a wacky guy named Mr. Market. Mr. Market's game is to pay you house calls every day, and he offers to sell you interests in businesses he owns or to buy from you interests in businesses you own. Sometimes Mr. Market shows up at your door very excited, and offers you premium prices for your holdings. Other times he is inconsolably depressed about the future and will offer to sell you what he has for as low as pennies on the dollar.
So to find some of those stocks that make Mr. Market weepy, I turn once again to The Motley Fool's CAPS investor community. Each of the companies below had been given a five-star rating (the highest) by our community of investors just 30 days ago:
Stock
30-day Return
One-year Return
Current CAPS Rating
Sigma Designs (Nasdaq: SIGM)
(34.0%)
13.1%
****
Ceradyne (Nasdaq: CRDN)
(19.5%)
(30.7%)
*****
Hardinge (Nasdaq: HDNG)
(18.6%)
(43.1%)
*****
Actuate (Nasdaq: ACTU)
(18.6%)
(2.7%)
****
Gen-Probe (Nasdaq: GPRO)
(10.6%)
8.7%
****
China Security & Surveillance Technology (NYSE: CSR)
(9.2%)
0.0%
*****
ASML Holding (Nasdaq: ASML)
(8.7%)
(0.5%)
*****
Data from Motley Fool CAPS as of Feb. 26.
As the table shows, these stocks are all still highly regarded by the CAPS community despite their underperformance over the past month. These are not formal recommendations, but they could be a great place to kick off further research.
Recent ACTU News
- Form 8-K - Current report • Edgar (US Regulatory) • 05/22/2026 08:43:53 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/22/2026 08:15:21 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/22/2026 08:10:59 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/22/2026 08:04:58 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/22/2026 08:03:42 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/22/2026 08:02:24 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 05/14/2026 08:06:37 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/14/2026 08:01:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/11/2026 09:27:24 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 05/06/2026 08:00:12 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 05/06/2026 02:15:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/06/2026 01:45:08 PM
- Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 04/22/2026 07:24:29 PM
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 04/09/2026 08:04:02 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 04/06/2026 08:06:56 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 04/06/2026 08:06:21 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/01/2026 09:19:31 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/26/2026 08:00:51 PM
- Actuate Therapeutics: Poised for Potential $200M+ Pediatric Priority Review Vouchers and Transformative Combinations in RAS-Driven Cancers • ACCESS Newswire • 03/24/2026 11:00:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/12/2026 09:00:25 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 12/11/2025 09:22:55 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/28/2025 10:21:45 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/28/2025 10:19:58 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/21/2025 09:30:42 PM
